Key Regulatory Trends Shaping Immuno-Oncology Development

Immuno‑oncology has ushered in a new era of cancer treatment, transforming survival outcomes and patient experiences. Regulatory agencies worldwide are adapting swiftly to accommodate the complexity of these therapies while ensuring patient safety and data integrity. From adaptive trial designs to ethical oversight, the evolving landscape requires a keen understanding of current trends and expectations. […]